Results 1 to 10 of about 265,457 (270)
Untypical Amlodipine-Induced Gingival Hyperplasia [PDF]
Case Reports in Dentistry, 2015 Amlodipine is a third generation dihydropyridine calcium channel blocker that is frequently used in therapy of hypertension. Among many side effects, amlodipine has been found associated with gingival overgrowth (GO) which usually occurs within the first
Verica Pavlic +3 more
doaj +7 more sources
Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
Journal of Pharmacy and Bioallied Sciences, 2023 Hypertension rightfully termed as “Silent killer” is associated with increase in morbidity and mortality when left untreated. Calcium channel blockers are the most commonly prescribed first-line anti-hypertensive drugs in India.
G Agnes Golda Priyadarshini +4 more
doaj +3 more sources
Levetiracetam-induced gingival hyperplasia.
J Postgrad Med, 2022 Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neurotransmitters. Gingival hyperplasia is a common side effect of conventional antiseizure medications like phenytoin, but very rare with the newer ones.
James J, Jose J, Gafoor VA.
europepmc +4 more sources
Amlodipine-Induced Gingival Hyperplasia in a Young Male with Stage 5 Chronic Kidney Disease [PDF]
Case Reports in Nephrology, 2020 Gingival hyperplasia is a rare finding in clinical practice. Nevertheless, when it occurs, it is a finding of great value as it can lead to definite clinical diagnosis.
Kevin John +3 more
doaj +3 more sources
Localized juvenile spongiotic gingival hyperplasia
Journal of Indian Society of Periodontology, 2023 Localized juvenile spongiotic gingival hyperplasia (LJSGH) is a poorly understood entity and is probably a misnomer too. Although this lesion is thought to be predominantly found in young children, a significant number of cases have also been reported in
Nitya Kala, Harikrishnan Prasad
doaj +4 more sources
Gingival hyperplasia induced by Nifedipine: case report [PDF]
Stomatološki glasnik Srbije, 2002 Nifedipine, a calcium channel blocker, is commonly used in the treatment of cardiovascular disorders. In this paper a case report is presented which describes a patient medicated with Nifedipine for angina pectoris and arterial hypertension, who ...
Đurić Milanko, Pićurić Ivana
doaj +5 more sources
Amlodipine-induced gingival hyperplasia: A report of two cases
Journal of Clinical and Scientific Research, 2022 Drugs associated with gingival overgrowth fall into three broad categories – anticonvulsants, immune suppressants and calcium channel blockers. Amlodipine is a third-generation dihydropyridine. The prevalence of amlodipine-induced gingival hyperplasia is
G Sri Lakshmi +5 more
doaj +2 more sources
Spongiotic Gingival Hyperplasia in a Child with Asperger Syndrome: a Case Report [PDF]
eJournal of Oral Maxillofacial Research, 2023 Background: Asperger syndrome is a type of autism spectrum disorder that may affect oral health and dental management. Spongiotic gingival hyperplasia is a rare lesion with unique clinicopathological features and unknown pathogenesis that has not been ...
Aikaterini Aktypi-Bampouranou +4 more
doaj +2 more sources
Oral Juvenile Xanthogranuloma: a case report of gingival hyperplasia and osteolysis in male adult patient [PDF]
BMC Oral Health, 2022 Background Juvenile Xanthogranuloma (JXG) is a non-hereditary, self-limiting disease which is usually presented in infancy or early childhood and in males over females.
Long Chen, Lin Feng, Lingling E
doaj +2 more sources
Cytomegalovirus-Induced Gingival Hyperplasia [PDF]
Clinical Infectious Diseases, 2003 We report a rare presentation of gingival hyperplasia associated with cytomegalovirus infection in a 33-year-old human immunodeficiency virus-infected man.
Jasjeet Kaur +2 more
openalex +3 more sources